157555-32-3

Upstream product

• 87787-12-0 1-methyl-t-4-(2-tetrahydropyranyloxy)-r-1-cyclohexanemethanol 

Downstream Products

• 157555-34-5 2-{4-[(E)-2-(4-Chloro-phenyl)-vinyl]-4-methyl-cyclohexyloxy}-tetrahydro-pyran 
• 157555-33-4 (R,S)-<1α,4β(E)>-2-<<4-<2-(3-chlorophenyl)ethenyl>-4-methylcyclohexyl>oxy>tetrahydro-2H-pyran 
• 157555-35-6 d,l-<1α(E),4β>-2-<<1,1-dimethyl-5-<3-<2-<1-methyl-4-<(tetrahydro-2H-pyran-2-yl)oxy>cyclohexyl>ethenyl>phenyl>pentyl>oxy>tetrahydro-2H-pyran 
• 157555-36-7 C₃₂H₅₀O₄ 
• 157555-28-7 4-{(E)-2-[3-(5-Hydroxy-5-methyl-hexyl)-phenyl]-vinyl}-4-methyl-cyclohexanol 
• 157555-29-8 4-{(E)-2-[4-(5-Hydroxy-5-methyl-hexyl)-phenyl]-vinyl}-4-methyl-cyclohexanol 

Relevant academic research and scientific papers

Design and synthesis of seco-oxysterol analogs as potential inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase gene transcription

The synthesis and biological activity of a series of seco-oxysterol analogs designed to be inhibitors of transcription of the gene for 3- hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGR) are described. The compound possessing the most significant acti